Peripheral Blood ETASTs for Predicting Efficacy of Chemoimmunotherapy in NSCLC

NCT07392073 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Non-Small Cell Lung Cancer
Lung Adenocarcinoma
Lung Squamous Cell Carcinoma
Stage IIIB Non-Small Cell Lung Cancer
Stage IV Non-Small Cell Lung Cancer
Advanced Non-Small Cell Lung Cancer

Interventions

DIAGNOSTIC_TEST: Circulating Tumor-Specific T Cell Nanodetection Technology (CTT-NanoDT)

Sponsor

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine